Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.

Date:

24 Mar,2023

Public Notice Draft for Wanbangde Pharmaceutical Group Co., Ltd.'s Annual Production Project of 2,195 Tons of Active Pharmaceutical Ingredients (Phase I)

The full text is attached.

Good News | Wanbangde Pharmaceutical Group has once again earned two prestigious awards: "Outstanding Chinese Ethnic Medicine Brand Enterprise" and "Top 50 Growing Companies in China's Pharmaceutical Industry"!

Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!

Related Recommendations

2025/01/21

Good News | Wanbangde Pharmaceutical Group's WP103 (Huperzine A Injection) Receives U.S. FDA Approval for Clinical Trials

2025/01/21

Good News | Wanbangde Pharmaceutical Group’s WP107 (Huperzine A Oral Solution) Receives U.S. FDA Approval for Clinical Trials

2025/01/13

Good News | Wanbangde Pharmaceutical Group's Cefaclor Granules Pass Consistency Evaluation!

< 1 2 3 4...78 > proceed page

Website Development: China Enterprise Dynamics Taizhou

Business license